Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen

Institut für Physiologische Chemie und Pathobiochemie

Vorklinik / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Muller, WEG; Wang, XH; Schroder, HC et al.

A cryptochrome-based photosensory system in the siliceous sponge Suberites domuncula (Demospongiae)

FEBS JOURNAL. Bd. 277. H. 5. 2010 S. 1182-1201


Wang, XH; Müller, WEG

Are Polymetallic Nodules, Crusts and Vents Biominerals?

Journal des Sciences Halieutiques et Aquatiques. Bd. 2. 2010 S. 5-20


Schladt, TD; Shukoor, MI; Schneider, K et al.

Au@MnO Nanoflowers: Hybrid Nanocomposites for Selective Dual Functionalization and Imaging

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. Bd. 49. H. 23. 2010 S. 3976-3980


Quarta, C; Bellocchio, L; Mancini, G et al.

CB1 Signaling in Forebrain and Sympathetic Neurons Is a Key Determinant of Endocannabinoid Actions on Energy Balance

CELL METABOLISM. Bd. 11. H. 4. 2010 S. 273-285


Storr, MA; Bashashati, M; Hirota, C et al.

Differential effects of CB1 neutral antagonists and inverse agonists on gastrointestinal motility in mice

NEUROGASTROENTEROLOGY AND MOTILITY. Bd. 22. H. 7. 2010 S. -


Kodirov, SA; Jasiewicz, J; Amirmahani, P et al.

Endogenous cannabinoids trigger the depolarization-induced suppression of excitation in the lateral amygdala

LEARNING & MEMORY. Bd. 17. H. 1. 2010 S. 832-838


Porten, E; Seliger, B; Schneider, VA et al.

The Process-inducing Activity of Transmembrane Agrin Requires Follistatin-like Domains

JOURNAL OF BIOLOGICAL CHEMISTRY. Bd. 285. H. 5. 2010 S. 3114-3125


Manthey, D; Gamerdinger, M; Behl, C

The selective beta(1)-adrenoceptor antagonist nebivolol is a potential oestrogen receptor agonist with neuroprotective abilities

BRITISH JOURNAL OF PHARMACOLOGY. Bd. 159. H. 6. 2010 S. 1264-1273


Bondesson, M; Jonsson, J; Pongratz, I et al.

A CASCADE of effects of bisphenol A.

Reprod Toxicol. Bd. 28. H. 4. 2009 S. 563-7


Chung, SC; Hammarsten, P; Josefsson, A et al.

A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer

EUROPEAN JOURNAL OF CANCER. Bd. 45. H. 1. 2009 S. 174-182